Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Rhea-AI Summary
Outset Medical (Nasdaq: OM) will release its second quarter 2026 financial results after the market close on Thursday, August 6, 2026. On the same day at 1:30 p.m. PT (4:30 p.m. ET), Chair and CEO Leslie Trigg and CFO Renee Gaeta will host a conference call, accessible via the Investors section of the company’s website or by telephone registration.
Positive
- None.
Negative
- None.
News Market Reaction – OM
In the Jul 23 session, OM gained 2.42%, reflecting a moderate positive market reaction. Argus tracked a trough of -6.7% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 27 | earnings date | Neutral | -2.0% | Scheduled first-quarter results release and conference call details |
| Jan 26 | earnings date | Neutral | +14.3% | Scheduled fourth-quarter and full-year results release with conference call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Comparable earnings-date notices produced mixed 24-hour reactions of -2.04% and 14.29%.
Key Terms
dialysis medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026.
On the same day, at 1:30 p.m. PT (4:30 p.m. ET), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss the results.
Conference Call Details
Those interested in accessing the live or archived version of the conference call can visit the “Investors” section of the Outset Medical website at https://investors.outsetmedical.com. Those interested in participating in the call via telephone may register online at this link. Once registered, participants will receive a dial-in number and unique PIN to join the call. Participants are encouraged to register more than 15 minutes before the start of the call.
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.
Investor Contact
investors@outsetmedical.com
